ipratropium



ipratropium

N + O O O H

SMILES CC(C)[N+]1(C)C2CCC1CC(OC(=O)C(CO)c1ccccc1)C2
InChIKey OEXHQOGQTVQTAT-UHFFFAOYSA-N

Chemical Properties

Hydrogen bond acceptors 3
Hydrogen bond donors 1
Rotatable bonds 5
Molecular weight (Da) 332.2


Bioactivities

ipratropium

N + O O O H

Drug properties

Molecular type Small molecule
Physiological/Surrogate Surrogate
Approved drug Yes

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV


Compound is not listed as a drug.